___

• Acar, M., Jafar-Nejad, H., Takeuchi, H., Rajan, A., Ibrani, D., Rana, N. A., Bellen, H. J. (2008). Rumi is a CAP10 domain glycosyltransferase that modifies Notch and is required for Notch signaling. Cell, 132(2), 247-258.
• Arasada RR, Amann JM, Rahman MA, Huppert SS, Carbone DP (2014) EGFR blockade enriches for lung cancer stemlike cells through Notch3-dependent signaling. Cancer Res 74(19):5572–5584.
• Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999). Notch signaling: cell fate control and signal integration in development. Science, 284(5415), 770-776.
• Basseres, D., & Baldwin, A. (2006). Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression. Oncogene, 25(51), 6817-6830.
• Beg, A. A., William, C. S., Bronson, R. T., Ghosh, S., & Baltimore, D. (1995). Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB.
• Beverly, L. J., Felsher, D. W., & Capobianco, A. J. (2005). Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression. Cancer research, 65(16), 7159-7168.
• Boggs, K., Henderson, B., & Reisman, D. (2009). RBP‐Jκ binds to and represses transcription of the p53 tumor suppressor gene. Cell biology international, 33(3), 318-324.
• Brzozowa-Zasada, M., Piecuch, A., Dittfeld, A., Mielańczyk, Ł., Michalski, M., Wyrobiec, G., ... & Wojnicz, R. (2016). Notch signalling pathway as an oncogenic factor involved in cancer development. Contemp Oncol (Pozn), 20(4), 267-272.
• Cheng, P., Zlobin, A., Volgina, V., Gottipati, S., Osborne, B., Simel, E. J., Gabrilovich, D. I. (2001). Notch-1 regulates NF-κB activity in hemopoietic progenitor cells. The Journal of Immunology, 167(8), 4458-4467.
• Dallman, M. J., Smith, E., Benson, R. A., & Lamb, J. R. (2005). Notch: control of lymphocyte differentiation in the periphery. Current opinion in immunology, 17(3), 259-266.
• Dang, T. P. (2012). Notch, apoptosis and cancer Notch Signaling in Embryology and Cancer (pp. 199-209): Springer.
• Haruki N, Kawaguchi KS, Eichenberger S, Massion PP, Olson S, Gonzalez A, Carbone DP, Dang TP (2005) Dominant-negative Notch3 receptor inhibits mitogen activated protein kinase pathway and the growth of human lung cancers. Cancer Res 65(9):3555–3561.
• Hassan KA, Wang L, Korkaya H, Chen G, Maillard I, Beer DG, Kalemkerian GP, Wicha MS (2013) Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma. Clin Cancer Res 19(8):1972–1980.
• Hassan WA, Yoshida R, Kudoh S, Hasegawa K, Niimori-Kita K, Ito T (2014) Notch1 controls cell invasion and metastasis in small cell lung carcinoma cell lines. Lung Cancer 86(3):304–310.
• Hassan, Wael Abdo, et al. "Evaluation of role of Notch3 signaling pathway in human lung cancer cells." Journal of cancer research and clinical oncology 142.5 (2016): 981-993.
• Kerr, J. F., Wyllie, A. H., & Currie, A. R. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. British journal of cancer, 26(4), 239.
• Kidd, S., Kelley, M. R., & Young, M. W. (1986). Sequence of the notch locus of Drosophila melanogaster: relationship of the encoded protein to mammalian clotting and growth factors. Molecular and cellular biology, 6(9), 3094-3108.
• Kiyohara, C., & Ohno, Y. (2010). Sex differences in lung cancer susceptibility: a review. Gender medicine, 7(5), 381-401.
• Konishi J, Kawaguchi KS, Vo H, Haruki N, Gonzalez A, Carbone DP, Dang TP (2007) Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. Cancer Res 67(17):8051–8057.
• Kopan, R. (2002). Notch: a membrane-bound transcription factor. Journal of cell science, 115(6), 1095-1097.
• Kramer, H. (2000). RIPping notch apart: a new role for endocytosis in signal transduction? Science Signaling, 2000(29), pg1.
• Krauss, G. (2006). Biochemistry of signal transduction and regulation: John Wiley & Sons.
• Ladanyi, M., Cha, C., Lewis, R., Jhanwar, S. C., Huvos, A. G., & Healey, J. H. (1993). MDM2 gene amplification in metastatic osteosarcoma. Cancer research, 53(1), 16-18.
• Lee S, Jung C, Ko Y, Choi J, Lee K, Kang C (2008) Expression of Notch 1 and 3 is related to inhibition of lymph node metastasis and progression in non-small lung carcinoma. Basic Appl Pathol 1(2):93–97.
• Li GG, Li L, Li C, et al. Influence of up-regulation of Notch ligand DLL4 on biological behaviors of human gastric cancer cells. World J Gastroenterol 2013; 19: 4486-94.
• Liu L, Chen X, Wang Y, Qu Z, Lu Q, Zhao J, Yan X, Zhang H, Zhou Y (2014) Notch3 is important for TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer bone metastasis by regulating ZEB-1. Cancer Gene Ther 21(9):364–372.
• Miele, L. (2006). Notch signaling. Clinical Cancer Research, 12(4), 1074-1079.
• Mullendore ME, Koorstra JB, Li YM, Offerhaus GJ, Fan X, Hender- son CM, et al. Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer. Clin Cancer Res 2009; 15: 2291-301.
• Oakley, F., Mann, J., Ruddell, R. G., Pickford, J., Weinmaster, G., & Mann, D. A. (2003). Basal expression of IκBα is controlled by the mammalian transcriptional repressor RBP-J (CBF1) and its activator Notch1. Journal of Biological Chemistry, 278(27), 24359-24370.
• Ohishi, K., Varnum-Finney, B., Flowers, D., Anasetti, C., Myerson, D., & Bernstein, I. D. (2000). Monocytes express high amounts of Notch and undergo cytokine specific apoptosis following interaction with the Notch ligand, Delta-1. Blood, 95(9), 2847-2854.
• Pazarbaşı, A., Kasap, H., & KASAP, M. (2011). Kanser Yolakları. Arşiv, 20, 187-229.
• Roy M, Pear WS, Aster JC (2007) The multifaceted role of Notch in cancer. Curr Opin Genet Dev 17(1):52–59.
• Sanchez-Cespedes, M., Reed, A. L., Buta, M., Wu, L., Westra, W. H., Herman, J. G., Sidransky, D. (1999). Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer. Oncogene, 18(43), 5843-5849.
• Schulz, W. A. (2005). Molecular biology of human cancers (Vol. 464): Springer.
• Vousden, K. H., & Lane, D. P. (2007). p53 in health and disease. Nature reviews Molecular cell biology, 8(4), 275-283.
• Wael H, Yoshida R, Kudoh S, Hasegawa K, Niimori-Kita K, Ito T (2014) Notch1 signaling controls cell proliferation, apoptosis and differentiation in lung carcinoma. Lung Cancer 85(2):131–140.
• Wharton, K. A., Johansen, K. M., Xu, T., & Artavanis-Tsakonas, S. (1985). Nucleotide sequence from the neurogenic locus notch implies a gene product that shares homology with proteins containing EGF-like repeats. Cell, 43(3), 567-581.
• White, D. W., Roy, A., & Gilmore, T. D. (1995). The v-Rel oncoprotein blocks apoptosis and proteolysis of I kappa B-alpha in transformed chicken spleen cells. Oncogene, 10(5), 857-868.